superbugs

Genentech develop Antibiotic with potential to lead to new class of Antibiotics

https://pharmaphorum.com/partner-content/genentech-develop-antibiotic-with-potential-to-lead-to-new-class-of-antibiotics/

Challenges including Funding and Lack of Incentives Hinder Antimicrobial Resistance Research

https://pharmaphorum.com/partner-content/challenges-including-funding-and-lack-of-incentives-hinder-antimicrobial-resistance-research/

Registration Officially Opens for the 21st Annual Superbugs & Superdrugs Conference

https://pharmaphorum.com/partner-content/registration-officially-opens-for-the-21st-annual-superbugs-superdrugs-conference/

https://pharmaphorum.com/events/21st-annual-superbugs-superdrugs-conference/

Antibiotic Class Emerges through Digestive Enzyme

https://pharmaphorum.com/partner-content/antibiotic-class-emerges-through-digestive-enzyme-2/

SMi’s Exclusive Interview with Mark Albrecht just released

https://pharmaphorum.com/partner-content/smis-exclusive-interview-with-mark-albrecht-just-released/

Superbugs & Superdrugs USA

https://pharmaphorum.com/events/superbugs-superdrugs-usa/

Novartis to cease antibiotic R&D despite superbug threat

https://pharmaphorum.com/news/novartis-will-cease-reasearch-development-into-antibiotics-layoff-140-employees/

Brexit warning sounded on EU public health system

https://pharmaphorum.com/news/brexit-health-alliance-eu-ewrs/

1 2

Close in 10 seconds

Pharmaphorum.com

Search